BIOPTRAIN - Bioinformatics & Optimisation Training
From 01-09-2005 to 31-08-2009
Website: http://bioptrain.org/
Description
Completion of the sequencing of the entire human genome and other major technological advances in bioinformatics have opened up a huge range of scientific challenges that will need to be addressed in order to maintain Europe’s scientific and commercial competitiveness and effectiveness in this emerging area of healthcare. An FP6 Network of Excellence, BIOPATTERN, has been established to integrate leading institutes around Europe to form a virtual institute for the study of individualised healthcare. The overall grand vision of BIOPATTERN is to integrate the analysis of the nano level bioinformatic data with micro level biosignal data and macro level patient information data in a pan-European cooperative research effort to combat major disease classes. Selected members of BIOPATTERN (University of Nottingham, UK (UoN) , University of Florence, Italy (UoF), Katholieke Universiteit Leuven, Belgium (KUL) , University College of Borås, Sweden (UCB) and Poznan University of Technology, Poland (PUT) ) will form the core of the BIOPTRAIN EST, the aim of which is to establish a complementary wide-ranging training programme of world-class quality in bioinformatic optimisation algorithms. There are two crucial groups of beneficiaries: (i) the next generation of European scientists must be trained to take advantage of the latest advances in bioinformatics with an aim of creating a vibrant, future-proof and self-sustaining research effort; and (ii) benefits from bioinformatics advances worldwide must be targeted to the European citizen – we cannot depend on research communities based in the USA and elsewhere to meet the specific needs of European healthcare.
Team
- Yves Moreau, Coordinator
- Bart De Moor, Promoter
Financing
Funding: EU Funding - European Funding
Program/Grant Type: EU Other - Other
Events
2/09/2024:
PhD defense - Martijn Oldenhof
Machine Learning for Advanced Chemical Analysis and Structure Recognition in Drug Discovery
3/09/2024:
Meet the Jury Igor Tetko on Advanced Machine Learning in Drug Discovery
12/09/2024:
Multimodal analysis of cell-free DNA for sensitive cancer detection in low-coverage and low-sample settings
Seminar by Antoine Passemiers
News
STADIUS Alumni Herman Verrelst – new CEO of Biocartis
08 June 2017
Herman Verrelst, the founder of KU Leuven spin-off Cartagenia, who has been working in Silicon Valley, US for the last few years will be returning to Belgium to follow the steps of Rudi Pauwels as CEO of the Belgian diagnostic company, Biocartis.
Supporting healthcare policymaking via machine learning – batteries included!
29 May 2017
STADIUS takes the lead in the data analytics efforts in an ambitious European Project MIDAS.
Marc Claesen gives an interview about his PhD for the magazine of the Faculty of Engineering Sciences "Geniaal"
10 February 2017
Did you know that in Belgium approximately one third of type 2 diabetes patients are unaware of their condition?
Joos Vandewalle is nieuwe voorzitter KVAB
09 October 2016
Op 5 oktober 2016 heeft de Algemene Vergadering van de Academie KVAB Joos Vandewalle verkozen tot voorzitter van de KVAB.